Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Atai Life Sciences N.V. (NQ: ATAI )

1.640 +0.120 (+7.89%)
Streaming Delayed Price Updated: 10:59 AM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Atai Life Sciences N.V.

< Previous 1 2
...
16 17 18 19 20 21 22 23 24
...
26 27 Next >
Psychedelic Stock Gainers And Losers From May 9, 2022
GAINERS: LOSERS: ATAI Life Sciences (NASDAQ:ATAI) shares closed down 13.47% at $3.34 
Via Benzinga
Psychedelic Stocks Continue To Decline In May
The 10 companies in our Psychedelic Compounds-Based Drug Stocks Index are clinical-stage startups still in the product research and development of novel compounds with no products and no revenue. 
Via Talk Markets
TripAdvisor, Field Trip Health Among Top Psychedelic Movers Of Today
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 9.40% at $0.16 
Via Benzinga
GH Research, Intelgenx Technologies Among Top Psychedelic Movers Of Today
GAINERS: TripAdvisor (NASDAQ:TRIP) shares closed up 5.09% at $25.80 LOSERS: 
Via Benzinga
Intelgenx Technologies, Field Trip Health Among Top Psychedelic Movers Of Today
GAINERS: Intelgenx Technologies (OTC:IGXT) shares closed up 13.21% at $0.30 
Via Benzinga
Allied, ATAI Life Sciences Among Top Psychedelic Movers Of Today
GAINERS: Allied (OTC:ALID) shares closed up 5.27% at $0.76 
Via Benzinga
Psyched: Elon Musk Praises Psychedelics Over Antidepressants, Field Trip To Split In Two, Colorado MDMA Bill Moves Forward
The world’s richest man gave another public nod to psychedelics medicine in favor of traditional mental health solutions. 
Via Benzinga
Compass Pathways, Small Pharma Among Top Psychedelic Movers Of Today
GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 8.17% at $9.80 
Via Benzinga
Cathie Wood Finds Elon Musk's Comment On Psychedelics, Ketamine An 'Interesting Thesis' For This Stock
Popular stock picker Cathie Wood said on Sunday she finds Tesla Inc (NASDAQ: TSLA) CEO Elon Musk’s comments on the effectiveness of psychedelics and other plant-based substances as treatments for... 
Via Benzinga
Field Trip Health, Revive Therapeutics Among Top Psychedelic Movers Of Today
GAINERS: Cybin (AMEX:CYBN) shares closed up 3.67% at $0.57 LOSERS: 
Via Benzinga
ATAI Life Sciences Present A "New Recipe For Success" At The Psychedelic Capital Conference
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. 
Via Benzinga
Psychedelic Stock Gainers And Losers From April 28, 2022
GAINERS: Field Trip Health (NASDAQ:FTRP) shares closed up 4.35% at $1.20 
Via Benzinga
Psychedelic Stock Gainers And Losers From April 27, 2022
GAINERS: Intelgenx Technologies (OTC:IGXT) shares closed up 3.77% at $0.28 
Via Benzinga
Psychedelic Stock Gainers And Losers From April 26, 2022
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 3.61% at $0.29 
Via Benzinga
ATAI Life Sciences, Compass Pathways Among Top Psychedelic Movers Of Today
GAINERS: ATAI Life Sciences (NASDAQ:ATAI) shares closed up 3.97% at $4.97 
Via Benzinga
Psyched: Big Pharma's Sanofi Enters Psychedelics Space, DNA From 80 Psilocybe Mushrooms Published Online, Maine Psychedelics Bill Shelved
Benzinga’s first-ever Psychedelics Capital Conference was a colossal success. Over 600 investors, policymakers, industry executives and thought leaders gathered at the Fontainebleau Hotel in Miami... 
Via Benzinga
Missed The Benzinga Psychedelics Capital Conference? Check Out Full Recording And Exclusive Coverage
Benzinga’s first-ever Psychedelics Capital Conference was a colossal success. Over 600 investors, policymakers, industry executives and thought leaders gathered at the Fontainebleau Hotel in Miami... 
Via Benzinga
Big Pharma's Sanofi Enters Licencing Agreement With Private Psychedelics Company Terran
Terran Biosciences is slowly but surely finding its place in the psychedelics industry. 
Via Benzinga
Shark Tank's Kevin O'Leary Says Twitter's Biggest Risk Is If Elon Musk 'Goes Away'
Shark Tank investor Kevin O’Leary hopes that Tesla Inc (NASDAQ: TSLA) CEO Elon Musk will be successful in his attempt to take over Twitter (NYSE: 
Via Benzinga
Field Trip Health, Mind Medicine Among Top Psychedelic Movers Of Today
GAINERS: Mind Medicine (NASDAQ:MNMD) shares closed up 3.49% at $0.87 
Via Benzinga
Revive Therapeutics, Field Trip Health Among Top Psychedelic Movers Of Today
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 20.83% at $0.29 
Via Benzinga
Roth Capital Reveals Top Psychedelic Picks in New Industry Report
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – April 21, 2022 – Investment banks are continuing to release positive coverage for psychedelic stocks and the latest report... 
Via FinancialNewsMedia
Psychedelic Stock Gainers And Losers From April 20, 2022
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 4.69% at $0.16 LOSERS: 
Via Benzinga
Jaden Smith Wants To Be A 'Psychedelics World Leader' After Trying Magic Mushrooms
In an interview with Complex to promote his clothing brand MSFTSrep, Jaden Smith talked about his experience with psychedelics and said he is looking to be a “psychedelics world leader.” 
Via Benzinga
Revive Therapeutics, Allied Among Top Psychedelic Movers Of Today
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 19.57% at $0.33 
Via Benzinga
EXCLUSIVE: ATAI Life Sciences Deploys Decentralized Approach To Transform Mental Health Treatments
ATAI Life Sciences NV (NASDAQ: ATAI) is deploying a multipronged approach to accelerate the development of mental health treatments. 
Via Benzinga
EXCLUSIVE: Breaking Down Public Vs. Private Psychedelic Investments
For many private companies, the goal is clear: to go public. For others, the goal is an acquisition. Either way, private companies offer attractive potential for investors, especially in emerging... 
Via Benzinga
EXCLUSIVE: Why Kevin O'Leary Of 'Shark Tank' Says Public Psychedelics Companies Will Need To Merge
The market opportunity for legal psychedelics is in the hundreds of billions of dollars, “Shark Tank” judge Kevin O’Leary told the inaugural Benzinga Psychedelics Capital Conference on Tuesday. 
Via Benzinga
Psychedelic Stock Gainers And Losers From April 18, 2022
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 14.66% at $0.28 
Via Benzinga
Psychedelic Stock Gainers And Losers From April 14, 2022
GAINERS: ATAI Life Sciences (NASDAQ:ATAI) shares closed up 2.50% at $5.32 
Via Benzinga
< Previous 1 2
...
16 17 18 19 20 21 22 23 24
...
26 27 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.